Publications<< Back
Escolar G, Diaz-Ricart M, Arellano-Rodrigo E, Galán AM
The pharmacokinetics of edoxaban for the prevention and treatment of venous thromboembolism.
Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):445-58, PMID: 24471416
Thromboembolic diseases will become the most important contributors to mortality and morbidity for modern societies. Current antithrombotic strategies using heparins or vitamin K antagonists are inconvenient, with limitations and inherent side effects. A series of new oral anticoagulants with powerful and reliable antithrombotic actions have been developed in the last decade.
BIOCHEMISTRY & MOLECULAR BIOLOGY
An initiative of
